Timothy Jones

Purisys LLC is a leading supplier of API CDMO services and pharmaceutical reference standards. The company is based in Athens, GA and has a 17,000-square-foot manufacturing facility and innovation center staffed by experienced professionals in complex high-barrier custom synthetic chemistry. Purisys specializes in controlled substance APIs and has 6 DEA registrations encompassing 48 drug codes. The company also stocks a catalog of more than 250 commercial reference standards that support pharmaceutical drug product development and manufacturing. In addition, Purisys is an ingredient and solutions provider to pharmaceutical and consumer products companies exploring CBD and other cannabinoid-based ingredients. The company maintains the broadest cannabinoid portfolio on the market, with experience producing commercial quantities of ingredients for over 10 years. James A Mish has been the CEO of the company since 2019.

Noramco, Inc. manufactures and supplies pharmaceutical products. Its products include controlled substances, medical devices, and active ingredients for various pharmaceutical companies. The company was founded in 1979 and is headquartered in Athens, GA.

QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX.

Part of Midas Pharma GmbH, Midas Pharmaceuticals, Inc. offers a broad portfolio of Consumer Healthcare and OTC products. The private company is based in Parsippany, NJ. Since its foundation, Midas Pharma has been offering services in sourcing and supplying of substances complying with the corresponding industry requirements and uses. Midas Pharma is a prominent and respected partner for pharmaceutical projects in the fields of custom synthesis, finished product development, supply and manufacture of drug substances and drug products, regulatory affairs, patents and in- and out-licensing.